abspara0015">We performed a multi-center parallel pragmatic randomized controlled trial in 120 general practices in the Netherlands. 203 patients, aged ≥45 years, with a new episode of hip complaints, complying with the ACR criteria for hip OA were randomized to the intervention group (
abspara0020">The overall estimates on hip pain and function during the 12-month follow-up showed no between-group difference (intention-to-treat). At 3-months follow-up there was a statistically significant between-group difference for HOOS pain −3.7 (95% CI: −7.3; −0.2), effect size −0.23 and HOOS function −5.3 (95% CI: −8.9; −1.6), effect size −0.31. No adverse events were reported.
abspara0025">No differences were found during 12-months follow-up on pain and function. At 3-months follow-up, pain and function scores differed in favor of patients allocated to the additional exercise therapy compared with GP care alone.
abspara0030">The Netherlands Trial Registry NTR1462.